Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer
AbstractAdvances in DNA- and RNA-based technologies have made gene therapy suitable for many lung diseases, especially those that are hereditary. The main objective of gene therapy is to deliver an adequate amount of gene construct to the intended target cell, achieve stable transduction in target cells, and to produce a clinically therapeutic effect. This review focuses on the cellular organization in the normal lung and how gene therapy targets the specific cell types that are affected by pulmonary disorders caused by genetic mutations. Furthermore, it examines the pulmonary barriers that can compromise the absorption and transduction of viral vectors and genetic agents by the lung. Finally, it discusses the advantages and limitations of direct intra-tracheal gene delivery with different viral vectors in small and large animal models and in clinical trials. View Full-Text
Share & Cite This Article
Katz, M.G.; Fargnoli, A.S.; Gubara, S.M.; Fish, K.; Weber, T.; Bridges, C.R.; Hajjar, R.J.; Ishikawa, K. Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer. J. Cardiovasc. Dev. Dis. 2019, 6, 8.
Katz MG, Fargnoli AS, Gubara SM, Fish K, Weber T, Bridges CR, Hajjar RJ, Ishikawa K. Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer. Journal of Cardiovascular Development and Disease. 2019; 6(1):8.Chicago/Turabian Style
Katz, Michael G.; Fargnoli, Anthony S.; Gubara, Sarah M.; Fish, Kenneth; Weber, Thomas; Bridges, Charles R.; Hajjar, Roger J.; Ishikawa, Kiyotake. 2019. "Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer." J. Cardiovasc. Dev. Dis. 6, no. 1: 8.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.